CD11b may be a less satisfactory indicator for cardiac ischemia-reperfusion injury in coronary artery bypass graft surgery with cardiopulmonary bypass than cardiac troponin I
- PMID: 15896579
- DOI: 10.1016/j.jclinane.2004.06.008
CD11b may be a less satisfactory indicator for cardiac ischemia-reperfusion injury in coronary artery bypass graft surgery with cardiopulmonary bypass than cardiac troponin I
Abstract
Study objective: To investigate whether CD11b on neutrophils can be used as a marker to predict myocardial ischemia-reperfusion injury for patients undergoing coronary artery bypass graft (CABG) surgery on cardiopulmonary bypass (CPB).
Design: Prospective, observational study.
Setting: University teaching hospital and university hospital laboratories.
Patients: Twelve adults, physical status II and III (American Society of Anesthesiologists) patients scheduled for elective CABG surgery on CPB.
Interventions: Anesthesia and surgical interventions were performed according to standard procedures. Coronary sinus was cannulated for retrograde cardioplegia perfusion and for coronary sinus blood sampling. The blood samples were collected from systemic and coronary venous sinus blood respectively at several time points before CPB, during CPB, and after declamping of the ascending aorta.
Measurements and main results: CD11b expressions in systemic circulation blood increased significantly during CPB and maintained higher levels after cardiac reperfusion (P < .05); on the other hand, CD11b expressions in coronary sinus blood declined gradually and reached their lowest level at 5 minutes after aortic declamping. The differences in CD11b expressions between systemic circulatory blood and coronary sinus blood after cardiac reperfusion were significant (P < .05). Cardiac troponin I (cTnI) concentrations in both systemic circulatory blood and coronary sinus blood increased significantly after cardiac reperfusion (P < .05), and the concentrations of cTnI in coronary sinus blood increased much higher than the corresponding concentrations of cTnI at each time point (P < .05).
Conclusion: CD11b expression on neutrophils may not be a reliable predictor for myocardial ischemia-reperfusion injury in CABG surgery on CPB because of the possible sequestration of neutrophils in myocardium.
Similar articles
-
High-sensitivity cardiac troponin T is more helpful in detecting peri-operative myocardial injury and apoptosis during coronary artery bypass graft surgery.Cardiovasc J Afr. 2015 Nov-Dec;26(6):234-41. doi: 10.5830/CVJA-2015-052. Epub 2015 Jul 14. Cardiovasc J Afr. 2015. PMID: 26212819 Free PMC article.
-
Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.Ann Vasc Surg. 2009 Sep-Oct;23(5):645-51. doi: 10.1016/j.avsg.2008.12.005. Epub 2009 May 21. Ann Vasc Surg. 2009. PMID: 19467834 Clinical Trial.
-
Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting.J Card Surg. 2008 Nov-Dec;23(6):681-7. doi: 10.1111/j.1540-8191.2008.00701.x. Epub 2008 Sep 5. J Card Surg. 2008. PMID: 18778302
-
Markers for perioperative myocardial ischemia: what both interventional cardiologists and cardiac surgeons need to know.Heart Surg Forum. 2005;8(5):E319-25. doi: 10.1532/HSF98.20051123. Heart Surg Forum. 2005. PMID: 16099733 Review.
-
Side effects of cardiopulmonary bypass: what is the reality?J Card Surg. 2004 Nov-Dec;19(6):481-8. doi: 10.1111/j.0886-0440.2004.04101.x. J Card Surg. 2004. PMID: 15548178 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials